Print

ADMA Biologics, Inc. Reports 2012 Third Quarter Results  
11/13/2012 9:27:18 AM

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today reported financial results for its third quarter ended September 30, 2012.
//-->